References
- Hall PD, Pilch N, Atchley DH. Chapter 95. Function and Evaluation of the Immune System. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. eds. Pharmacotherapy: A Pathophysiologic Approach, 8e. New York: McGraw-Hill; 2011. http://accesspharmacy.mhmedical.com/content.aspx?bookid=462&Sectionid=41100874. Accessed January 10, 2014.
- Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000; 343:37-49; PMID:10882768; http://dx.doi.org/10.1056/NEJM200007063430107
- Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588
- Flu vaccine effectiveness: questions and answers for health professionals. Centers for Disease Control and Prevention. Available at: www.cdc.gov/flu/professionals/vaccination/effectivenessqa.htm. Accessed on: January 9, 2014.
- Chaplin DD. 1. Overview of the human immune response. J Allergy Clin Immunol 2006; 117(Suppl Mini-Primer):S430-5; PMID:16455341; http://dx.doi.org/10.1016/j.jaci.2005.09.034
- Key facts about seasonal flu vaccine. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/flu/protect/keyfacts.htm. Accessed on January 9, 2014.
- Flu vaccines 2013-2014. Pharmacist's Letter/Prescriber's Letter Detail Document #291001. October 2013. Available at: www.pharmacistsletter.com. Accessed on January 9, 2014.
- Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, Iacuzio D, Wittes J, Bryant M. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 1999; 18:899-906; PMID:10580204; http://dx.doi.org/10.1016/S0264-410X(99)00334-5
- Jain VK, Rivera L, Zaman K, Espos RA Jr., Sirivichayakul C, Quiambao BP, Rivera-Medina DM, Kerdpanich P, Ceyhan M, Dinleyici EC, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med 2013; 369:2481-91; PMID:24328444; http://dx.doi.org/10.1056/NEJMoa1215817
- Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-96; PMID:17301299; http://dx.doi.org/10.1056/NEJMoa065368
- Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295-301; PMID:15525714; http://dx.doi.org/10.1056/NEJMoa043540
- Canadian National Advisory Committee on Immunization. Recommendations on the use of intradermal trivalent inactivated influenza vaccine (TIV-ID). Canada Communicable Disease Report 2011; 37(ACS-4): 1481-8531. Available at: www.phac-aspc.gc.ca/publicat/ccdr-rmtc/11vol37/acs-dcc-4/index-eng.php. Accessed on: January 9, 2014.
- Lowes R. Fluzone high-dose foils flu better in seniors, says maker. Medscape Medical News 2013. Available at: www.medscape.com/viewarticle/813203. Accessed on: January 9, 2014.
- Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med 2010; 363:2036-44; PMID:21083388; http://dx.doi.org/10.1056/NEJMra1002842